Sleep Medicine
Volume 7, Issue 5 , Pages 418-423 , August 2006

Use of pramipexole in REM sleep behavior disorder: Results from a case series

  • Markus H. Schmidt

      Affiliations

    • Ohio Sleep Medicine and Neuroscience Institute, 4975 Brandenton Avenue, Dublin, OH 43017, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 614 766 0773; fax: +1 614 766 2599.
    • ,
  • Vipin B. Koshal

      Affiliations

    • Riverside Methodist Hospital, Department of Internal Medicine, 3445 Olentangy River Road, Columbus, Ohio 43214, USA
    • ,
  • Helmut S. Schmidt

      Affiliations

    • Ohio Sleep Medicine and Neuroscience Institute, 4975 Brandenton Avenue, Dublin, OH 43017, USA

Received 30 December 2004 ,Revised 24 March 2006 ,Accepted 30 March 2006.

References 

  1. Schenck CH, Mahowald MW. REM sleep behavior disorder: clinical, developmental, and neuroscience perspectives 16 years after its formal identification in sleep. Sleep. 2002;25:120–138
  2. Schmidt HS, Monroe LJ. A case study of unusual chronic sleep disruption. Psychophysiology. 1969;6:232
  3. Schenck CH, Mahowald MW. Motor dyscontrol in narcolepsy: rapid eye-movement (REM) sleep without atonia and REM sleep behavior disorder. Ann Neurol. 1992;32:3–10
  4. Mayer G, Meier-Ewert K. Motor dyscontrol in sleep of narcoleptic patients (a lifelong development?).. J Sleep Res. 1993;2:143–148
  5. Schenck CH, Hurwitz TD, Mahowald MW. REM sleep behavior disorder: an update on a series of 96 patients and a review of the world literature. J Sleep Res. 1993;2:224–231
  6. Olson EJ, Boeve BF, Silber MH. Rapid eye movement sleep behavior disorder: demographic, clinical and laboratory findings in 93 cases. Brain. 2000;123:331–339
  7. Schuld A, Kraus T, Haack M, et al. Obstructive sleep apnea syndrome induced by clonazepam in a narcoleptic patient with REM-sleep-behavior disorder. J Sleep Res. 1999;8:321–322
  8. Albin RL, Koeppe RA, Chervin RD, et al. Decreased striatal dopaminergic innervation in REM sleep behavior disorder. Neurology. 2000;55:1410–1412
  9. Gilman S, Koeppe RA, Chervin RD, et al. REM sleep behavior disorder is related to striatal monoaminergic deficit in MSA. Neurology. 2003;61:29–34
  10. Eisensehr I, Linke R, Tatsch K, et al. Increased muscle activity during rapid eye movement sleep correlates with decrease striatal presynaptic dopamine transporters. IPT and IBZM SPECT imaging in subclinical and clinically manifest idiopathic REM sleep behavior disorder, parkinson's disease, and controls. Sleep. 2003;26:507–512
  11. Fantini ML, Gagnon JF, Filipini D, Montplaisir J. The effects of pramipexole in REM sleep behavior disorder. Neurology. 2003;61:1418–1420
  12. Berger RJ, et al. A manual of standardized terminology, techniques, and scoring system for sleep stages of human subjects. In:  Rechtschaffen A,  Kales A editor. Public health service. Washington, DC: US Government Printing Office; 1968;
  13. Bonnet M, Carley D, Carskadon M, et al. EEG arousals: scoring rules and examples. A preliminary report from the sleep disorders atlas task force of the American Sleep Disorders Association. Sleep. 1992;15:173–184
  14. Schmidt HS, Berendts BP. Respiratory arousal index and craniofacial abnormalities in UARS: potential indications for NCPAP usefulness. Sleep Res 1997;26:498.
  15. Matheson JK, Saper CB. REM sleep behavior disorder: a dopaminergic deficiency disorder?. Neurology. 2003;61:1328–1329

PII: S1389-9457(06)00109-2

doi: 10.1016/j.sleep.2006.03.018

Sleep Medicine
Volume 7, Issue 5 , Pages 418-423 , August 2006

Article Tools

* Image Usage & Resolution